Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 201–300 of 1,000
Subversion of host genome integrity by bacterial pathogens
Chumduri, C., Gurumurthy, R. K., Zietlow, R., & Meyer, T. F. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.100 · Cited by 84
Imaizumi, N., Monnier, Y., Hegi, M. E., Mirimanoff, R., & Rüegg, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011084 · Cited by 90
“To unravel the molecular mechanisms possibly involved in mediating these radiation effects, we initially focused on the P53P21 pathway for two reasons: first, this pathway is activated in irradiated endothelial cells, as a consequence of DNA double strand breaks and activation of DNA damage-sensing complexes [34] and,…”
BackgroundMeasuring In Vivo Protein Half-Life
Bojkowska, K., de Sio, F. R. S., Barde, I., Offner, S., Verp, S., Heinis, C., Johnsson, K., & Trono, D. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.014 · Cited by 89
Graphene-based immunosensor for electrochemical quantification of phosphorylated p53 (S15)
Xie, Y., Chen, A., Du, D., & Lin, Y. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.05.010 · Cited by 80
Mirza-Aghazadeh-Attari, M., Darband, S. G., Kaviani, M., Mihanfar, A., Aghazadeh Attari, J., Yousefi, B., & Majidinia, M. (2018) · DNA Repair · doi:10.1016/j.dnarep.2018.07.005 · Cited by 76
Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos
Stancheva, I., Hensey, C., & Meehan, R. R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1963 · Cited by 91
Soltis, A. R., Bateman, N. W., Liu, J., Nguyen, T. M., Franks, T. J., Zhang, X., Dalgard, C. L., Viollet, C., Somiari, S., Yan, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100819 · Cited by 93
p53 Inhibits Strand Exchange and Replication Fork Regression Promoted by Human Rad51
Yoon, D. J., Wang, Y., Stapleford, K. A., Wiesmüller, L., & Chen, J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.050 · Cited by 78
The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor
Lee, J. T., Beliakoff, J., & Sun, Z.-J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm476 · Cited by 87
“It has been shown that the transcriptional activity of p53 can be regulated by multiple post-translational modifications, including phosphorylation, ubiquitination and acetylation (52).”
Cigarette Smoke Activates Caspase-3 to Induce Apoptosis of Human Umbilical Venous Endothelial Cells
Wang, J., Wilcken, D. E. L., & Wang, X. L. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3115 · Cited by 78
Itoh, T., O'Shea, C., & Linn, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7540-7553.2003 · Cited by 73
“These changes allow p53 to mediate transcriptional activation of a number of genes (3, 30, 40).”
BackgroundBTK Modulates p53 Activity to Enhance Apoptotic and Senescent Responses
Althubiti, M., Rada, M., Samuel, J., Escorsa, J. M., Najeeb, H., Lee, K.-G., Lam, K., Jones, G. D. D., Barlev, N. A., & Macip, S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0690 · Cited by 78
“S2B). p53 is known to be phosphorylated by ATM, ATR, DNA-PK, and PKC (37), among other kinases.”
BackgroundInfluentialRotenone-induced oxidative stress and apoptosis in human liver HepG2 cells
Siddiqui, M. A., Ahmad, J., Farshori, N. N., Saquib, Q., Jahan, S., Kashyap, M. P., Ahamed, M., Musarrat, J., & Al-Khedhairy, A. A. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1781-9 · Cited by 84
“demonstrates that the up-regulation of Bax is due to the activated p53 and hence, it is in agreement with the observation on the collapse of MMP in mitochondria because Bax and Bax-like proteins have been reported to initiate caspase-independent death via channel forming activity, which promotes the mitochondrial perm…”
ResultA TPR Motif Cofactor Contributes to p300 Activity in the p53 Response
Demonacos, C., Krstic–Demonacos, M., & Thangue, N. B. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00277-5 · Cited by 90
Loss of poly(ADP‐ribose) polymerase‐1 causes increased tumour latency in p53‐deficient mice
Conde, C., Mark, M. P., Oliver, F. J., Huber, A., de MURCIA, G., & Murcia, J. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3535 · Cited by 83
Helicobacter pylori ‐induced DNA double‐stranded break in the development of gastric cancer
Murata‐Kamiya, N., & Hatakeyama, M. (2022) · Cancer Science · doi:10.1111/cas.15357 · Cited by 81
Dumaz, N., Milne, D., Jardine, L., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590459 · Cited by 75
Murakami, T., Fujimoto, M., Ohtsuki, M., & Nakagawa, H. (2001) · Journal of Dermatological Science · doi:10.1016/s0923-1811(01)00124-4 · Cited by 74
“The p53 transcription factor plays a crucial role at the G1/S-check point of the cell cycle and during apoptosis following UVB irradiation [17–20].”
BackgroundUberti, D., Carsana, T., Bernardi, E., Rodella, L., Grigolato, P., Lanni, C., Racchi, M., Govoni, S., & Memo, M. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3131 · Cited by 75
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
Li, Z., Hao, Q., Luo, J., Xiong, J., Zhang, S., Wang, W., Bai, L., Wang, W., Chen, M., Wang, W., et al. (2015) · Oncogene · doi:10.1038/onc.2015.349 · Cited by 79
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 70
“Many studies have shown that once the cells encounter DNA damage, multiple post-translational modifications occur, leading to an increase in p53 levels due to stabilization and an increase in p53 transcriptional activity (Lakin and Jackson, 1999; Saito et al., 2003).”
Backgroundp53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
Wu, C.-C., Yang, T., Yu, C. R., Phan, L. M., Ivan, C., Sood, A. K., Hsu, S., & Lee, M. (2012) · Cell Cycle · doi:10.4161/cc.21732 · Cited by 82
“p53 is activated in response to DNA damage, hypoxia and abnormal expression of oncogenes.(4,5) Upon activation, p53 is stabilized by dissociation from MDM2 and can trigger the transcription of a set of target genes (p21, GADD45, Puma or Bax) that arrest the cell cycle or induce cellular apoptosis (reviewed in ref.”
BackgroundDownregulation of transcription factor, Sp1, during cellular senescence
Oh, J., Han, J.-A., & Hwang, E. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.118 · Cited by 75
Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways
Gao, D., Inuzuka, H., Korenjak, M., Tseng, A., Wu, T., Wan, L., Kirschner, M. W., Dyson, N. J., & Wei, W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0092 · Cited by 81
“The p53 tumor suppressor protein is considered the major effector of DNA damage signals, eliciting a cellular response by activating either a G1 or G2 arrest through its transcriptional targets p21 or Gadd45a (Lakin and Jackson, 1999; Meek, 1999).”
Molecular signature of anastasis for reversal of apoptosis
Tang, H. M., Talbot, C. C., Fung, M. C., & Tang, H. L. (2017) · F1000Research · doi:10.12688/f1000research.10568.2 · Cited by 82
Tharmalingam, S., Sreetharan, S., Brooks, A. L., & Boreham, D. R. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.013 · Cited by 75
Othmène, Y. B., Monceaux, K., Karoui, A., Salem, I. B., Belhadef, A., Abid‐Essefi, S., & Lemaire, C. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111040 · Cited by 76
Shono, T., Tofilon, P. J., Schaefer, T. S., Parikh, D., Liu, T.-J., & Lang, F. F. (2002) · PubMed · Cited by 81
Capsaicin induced apoptosis of B16-F10 melanoma cells through down-regulation of Bcl-2
Jun, H.-S., Park, T., Lee, C. K., Kang, M. K., Park, M. S., Kang, H. I., Surh, Y., & Kim, O. H. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.10.011 · Cited by 70
Wang, J., Ouyang, W., Li, J., Wei, L., Ma, Q., Zhang, Z., Tong, Q., He, J., & Huang, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4184 · Cited by 76
Is There a Rationale for Neuroprotection Against Dopamine Toxicity in Parkinson's Disease?
Barzilai, A., Melamed, E., & Shirvan, A. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1010991020245 · Cited by 76
“…and Molecular Neurobiology [cemn] PP208-342434 July 31, 2001 10:26 Style file version Oct 23, 2000 226 Barzilai, Melamed, and Shirvan triggering either repair or apoptosis in response to moderate or severe damage, respectively (for review see Lakin and Jackson, 1999; Vogt-Sionov and Haupt, 1999).”
BackgroundAt a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity
Rizzotto, D., Englmaier, L., & Villunger, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910883 · Cited by 75
“, Ser15, Ser20, and Ser37) [68,69], leading to the displacement of MDM2 for p53 stabilization (Figure 1).”
BackgroundRepression of P53 Function by SIRT5-Mediated Desuccinylation at Lysine 120
Liu, X., Rong, F., Tang, J., Zhu, C., Chen, X., Jia, S., Wang, Z., Sun, X., Deng, H., Zha, H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-021-00886-w · Cited by 72
Defining the toxicology of aging
Sorrentino, J. A., Sanoff, H. K., & Sharpless, N. E. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.04.004 · Cited by 75
“…anu sc r i p t promote molecular aging, causing chronic changes in exposed tissues in the expression of multiple senescence biomarkers including expression of SASP factors [91, 92], LTL shortening [24, 93], and induction of p16 INK4a and other senescence-associated tumor suppressor genes [34, 94].”
BackgroundA Second p53 Binding Site in the Central Domain of Mdm2 Is Essential for p53 Ubiquitination
Ma, J., Martin, J. D., Zhang, H., Auger, K. R., Ho, T. F., Kirkpatrick, R. B., Grooms, M. H., Johanson, K. O., Tummino, P. J., Robert A. Copeland, A., et al. (2006) · Biochemistry · doi:10.1021/bi060661u · Cited by 68
Goudelock, D. M., Jiang, K., Pereira, E., Russell, B., & Sánchez, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301765200 · Cited by 76
Involment of p53, Bax, and Bcl‐2 pathway in microcystins‐induced apoptosis in rat testis
Li, G., Xie, P., Li, H., Hao, L., Xiong, Q., & Qiu, T. (2009) · Environmental Toxicology · doi:10.1002/tox.20532 · Cited by 70
Tumiatti, V., Milelli, A., Minarini, A., Micco, M., Campani, A. G., Roncuzzi, L., Baiocchi, D., Marinello, J., Capranico, G., Zini, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901131m · Cited by 74
Mathijs, K., Brauers, K. J. J., Jennen, D. G. J., Boorsma, A., van Herwijnen, M. H. M., Gottschalk, R. W. H., Kleinjans, J. C. S., & van Delft, J. H. M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp229 · Cited by 68
“This p53 is related to DNA damage responses as levels of p53 are increasing vary fast in cells sustaining DNA damage (Lakin and Jackson, 1999).”
Backgroundp53 activation in response to microtubule disruption is mediated by integrin-Erk signaling
Sablina, A. A., Chumakov, P. M., Levine, A. J., & Kopnin, B. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204156 · Cited by 79
“Noteworthy, other stresses that result p53 activation, such as g-irradiation (Levine, 1997; Lakin and Jackson, 1999) or disruption of actin micro®laments by cytochalasin D (Rubtsova et al., 1998), did not cause Erk1/2 phosphorylation in REF52 cells (Figure 4a).”
BackgroundInfluentialKrane, M., Dreßen, M., Santamaria, G., My, I., Schneider, C. M., Dorn, T., Laue, S., Mastantuono, E., Berutti, R., Rawat, H., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056198 · Cited by 69
Fazzio, T. G., & Panning, B. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200908026 · Cited by 76
“The transcriptional regulatory activity of p53 is regulated by several posttranslational modifications, including phosphorylation of residues within its amino-terminal transcriptional activation domain (Lakin and Jackson, 1999).”
Carbon Source Metabolism and Its Regulation in Cancer Cells
Yin, C., Qie, S., & Sang, N. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i1.20 · Cited by 75
Purohit, N. K., Shah, R. G., Adant, S., Hoepfner, M., Shah, G. M., & Beauregard, J. (2018) · Oncotarget · doi:10.18632/oncotarget.25266 · Cited by 70
“com The increased DNA damage is known to result in the phosphorylation-induced activation and accumulation of p53 via the ATM, ATR and DNA PKcs pathways [27, 28], which can lead to cell cycle arrest and/or apoptosis [34].”
BackgroundHIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function
Stefano, V. D., Blandino, G., Sacchi, A., Soddu, S., & D’Orazi, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207656 · Cited by 86
“The tumor suppressor p53 induces cell death by apoptosis in response to various stresses, such as oncogene activation or DNA damage (Giaccia and Kastan, 1998; Lakin and Jackson, 1999).”
BackgroundInfluentialDhanalakshmi, S., Agarwal, C., Singh, R. P., & Agarwal, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414640200 · Cited by 67
The Strength of Indecisiveness: Oscillatory Behavior for Better Cell Fate Determination
Lahav, G. (2004) · Science s STKE · doi:10.1126/stke.2642004pe55 · Cited by 69
Zheng, Z., Wu, D., Fan, S., Zhang, Z.-F., Chen, G., & Lu, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29182 · Cited by 69
“As a tumor inhibitor, P53 plays important roles in cellular responses, such as apoptosis and cell‐cycle arrest, following exposure to a variety of stresses including DNA damage.(39) In addition to its transcriptional activity, p53 can lead to the activation of mitochondrial‐induced transcriptional‐independent pathway…”
BackgroundReview on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway
P, P. S., Arthiga, K., Patil, A. B., Spandana, K. M. A., & Jain, V. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07369-2 · Cited by 72
“p53 protein is rapidly destroyed in normal settings due to its association with Mdm-2(a negative regulator of p53 tumor suppressor), which causes ubiquitination and proteasomal destruction [60].”
BackgroundRegulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
Jones, A. B., Rocco, A., Lamb, L. S., Friedman, G. K., & Hjelmeland, A. B. (2022) · Cancers · doi:10.3390/cancers14092339 · Cited by 73
Zhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 81
“Radiotherapy is widely used for the treatment of multiple cancer types and can induce irreparable DNA damage response that activates ATM or ATR and p53-p21 pathway-mediated apoptosis and cellular senescence [129, 140, 141].”
BackgroundMathieu, M.-C., Lapierre, I., Brault, K., & Raymond, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008495200 · Cited by 63
Nguyen, N. T., Kim, J., Le, X. T., Lee, W. T., Lee, E. S., Oh, K. T., Choi, H., & Youn, Y. S. (2022) · ACS Nano · doi:10.1021/acsnano.2c08706 · Cited by 68
Badar, T., Atallah, E., Shallis, R., Saliba, A. N., Patel, A., Bewersdorf, J. P., Grenet, J., Stahl, M., Duvall, A., Burkart, M., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01847-7 · Cited by 65
Telomeres, cellular senescence, and aging: past and future
Eppard, M., Passos, J. F., & Victorelli, S. G. (2023) · Biogerontology · doi:10.1007/s10522-023-10085-4 · Cited by 71
“One of the primary effector molecules downstream of the DDR is the transcription factor p53 (Lakin and Jackson 1999).”
Jossé, R., Dumont, J., Fautrel, A., Robin, M., & Guillouzo, A. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.019 · Cited by 65
Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation
Santoro, R., Mori, F., Marani, M., Grasso, G., Cambria, M. A., Blandino, G., Muti, P., & Strano, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt025 · Cited by 62
“When this occurs, a DNA repair response is induced, in which phosphorylated p53 plays a central role (19,21,44).”
BackgroundZhang, W.-Y., Du, F., He, M., Bai, L., Gu, Y., Yang, L.-L., & Liu, Y. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.009 · Cited by 65
D'Errico, M., Teson, M., Calcagnile, A., Nardo, T., De Luca, N., Lazzari, C., Soddu, S., Zambruno, G., Stefanini, M., & Dogliotti, E. (2005) · Cancer Research · doi:10.1158/0008-5472.432.65.2 · Cited by 64
Ali, A., Abedini, M. R., & Tsang, B. K. (2011) · Oncogene · doi:10.1038/onc.2011.399 · Cited by 64
Friesen, C., Lubatschofski, A., Kotzerke, J., Buchmann, I., Reske, S. N., & Debatin, K. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1216-z · Cited by 69
“p53 accumulates in response to DNA damage [ 35 , 37, 43] and p53 plays an important role in the cellular choice between life and death [43].”
BackgroundInfluentialSuppression of apoptosis: role in cell growth and neoplasia
White, M. K., & McCubrey, J. A. (2001) · Leukemia · doi:10.1038/sj.leu.2402143 · Cited by 72
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Germino-Watnick, P., Hinds, M., Le, A., Chu, R., Liu, X., & Uchida, N. (2022) · Cells · doi:10.3390/cells11111843 · Cited by 68
Ting, Y., Chiou, Y., Pan, M., Ho, C., & Huang, Q. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.034 · Cited by 63
Nohmi, T., & Masumura, K. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20110 · Cited by 65
Lee, H. H., Lee, S., Lee, K.-H., Shin, Y. S., Kang, H., & Cho, H. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0117-6 · Cited by 63
“p53 is known to play a critical role in the induction of cell apoptosis in response to DNA damage [18].”
BackgroundTelomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6
DeMaggio, A., Sundsvold, T., Wurscher, M. A., Koop, J. I., Klingelhutz, A. J., & McDougall, J. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207388 · Cited by 70
“Lack of p53, a transcription factor which mediates the expression of a variety of genes that induce a growth arrest or apoptosis, abrogates the cellular response to DNA damage (Lakin and Jackson, 1999).”
BackgroundLi, M., Lin, A., Luo, P., Shen, W., Xiao, D., Gou, L., Zhang, J., & Guo, L. (2020) · Aging · doi:10.18632/aging.102683 · Cited by 62
Li, L., Cao, W., Zheng, W., Fan, C., & Chen, T. (2012) · Dalton Transactions · doi:10.1039/c2dt30665d · Cited by 66
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Durinikova, E., Reilly, N. M., Buzo, K., Mariella, E., Chilà, R., Lorenzato, A., Dias, J. M. L., Grasso, G., Pisati, F., Lamba, S., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0875 · Cited by 59
“We then evaluated TP53, a tumor suppressor gene involved in the cell-cycle control and DDR activation (51).”
Hay, T. J., & Meek, D. W. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01850-0 · Cited by 62
AMF1 (GPS2) Modulates p53 Transactivation
Peng, Y., Kuo, F., Breiding, D. E., Wang, Y., Mansur, C. P., & Androphy, E. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5913-5924.2001 · Cited by 64
Anesthetic Isoflurane Induces DNA Damage Through Oxidative Stress and p53 Pathway
Ni, C., Li, C., Dong, Y., Guo, X., Zhang, Y., & Xie, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9937-8 · Cited by 63
“Activated p53, in response to DNA damage, then binds to DNA and mediates transcriptional activation, leading to the activation of a number of genes which promote DNA repair [[45, 61, 62], reviewed in [63]].”
Liu, P., Fu, W., Verwilst, P., Won, M., Shin, J. W., Cai, Z., Tong, B., Shi, J., Dong, Y., & Kim, J. S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916524 · Cited by 62
Kinetic Properties of p53 Phosphorylation by the Human Vaccinia-Related Kinase 1
Barcia, R., López-Borges, S., Vega, F. M. D. L., & Lazo, P. A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2746 · Cited by 72
Sopko, R., Raithatha, S. A., & Stuart, D. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7024-7040.2002 · Cited by 61
“Both p53 and CREB are activated by phosphorylation within their transactivation domains (12, 23).”
BackgroundKnockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
Blackburn, A. C., & Jerry, D. J. (2002) · Breast Cancer Research · doi:10.1186/bcr427 · Cited by 67
“The regulation of p53 stability and activity involves many proteins, such as the antagonist MDM2 that binds the transactivation domain and also targets p53 for ubiquitination and degradation, or the kinases DNA-PK and ATM that phosphorylate p53 at several of its many sites for post-translational modification [9,10].”
Portella, G., Scala, S., Vitagliano, D., Vecchio, G., & Fusco, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8529 · Cited by 61
Irod/Ian5: An Inhibitor of γ-Radiation- and Okadaic Acid-induced Apoptosis
Sandal, T., Aumo, L., Hedin, L., Gjertsen, B. T., & Døskeland, S. O. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-10-0700 · Cited by 67
“Ionizing radiation induces double strand breaks in DNA, whereas UV-C radiation is believed to induce apoptosis mainly through single-strand DNA damage (Lu et al., 1998; Lakin and Jackson, 1999).”
BackgroundHeylmann, D., Badura, J., Becker, H., Fahrer, J., & Kaina, B. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1095-7 · Cited by 67
TRPV1 Channels in Immune Cells and Hematological Malignancies
Omari, S. A., Adams, M. J., & GERAGHTY, D. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.01.002 · Cited by 63
Song, Y. J., Salbu, B., Heier, L. S., Teien, H., Lind, O. C., Oughton, D. H., Petersen, K., Rosseland, B. O., Skipperud, L., & Tollefsen, K. E. (2012) · Aquatic Toxicology · doi:10.1016/j.aquatox.2012.01.019 · Cited by 70
“consequence of exposure to DNA damaging agents (Lakin and Jackson, 1999; Wood and Shilatifard, 2006; Liebermann and Hoffman, 2007; Krumschnabel and Podrabsky, 2009; Lerebours et al., 2009).”
BackgroundInsulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
Werner, H., Sarfstein, R., LeRoith, D., & Bruchim, I. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00159 · Cited by 63
Cross-Talk between p53 and Wnt Signaling in Cancer
Xiao, Q., Werner, J., Venkatachalam, N., Boonekamp, K. E., Ebert, M. P. A., & Zhan, T. (2022) · Biomolecules · doi:10.3390/biom12030453 · Cited by 63
“MDM2 inhibitors are currently tested in advanced phase clinical trials as a treatment for hematological cancers [174].”
BackgroundInfluentialJiang, L., Wang, Y., Björn, L. O., & Li, S. (2011) · Planta · doi:10.1007/s00425-010-1340-5 · Cited by 68
“…that mammal and yeast cells can use G1 checkpoint to permit more time for DNA repair mechanism to act prior to semi-conservative replication and cytokinesis during genotoxic stress. p53 tumor suppressor protein plays an important role in DNA damage inducible-G1 arrest (Lakin and Jackson 1999).”
BackgroundMutated and non‐mutated TP53 as targets in the treatment of leukaemia
Nahi, H., Selivanova, G., Lehmann, S., Möllgård, L., Bengtzen, S., Concha, H., Svensson, A., Wiman, K. G., Merup, M., & Paul, C. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07046.x · Cited by 53
“DNA damage decreases the activity of HDM2 and the interaction between HDM2 and p53, which eventually results in stabilization of p53 (Lakin & Jackson, 1999), (Vogelstein et al, 2000) via phosphorylation of both p53 and HDM2 by the protein kinase ATM (Kojima et al, 2005).”
BackgroundNur‐E‐Kamal, A., Li, T., Zhang, A., Qi, H., Hars, E. S., & Liu, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212915200 · Cited by 60
Pohnke, Y., Schneider-Merck, T., Fahnenstich, J., Kempf, R., Christian, M., Milde-Langosch, K., Brosens, J. J., & Gellersen, B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0012 · Cited by 57
“DNA-binding and transcriptional activity of p53 are believed to be induced by posttranslational modifications in response to acute stress (65).”
BackgroundAbarikwu, S. O., Pant, A. B., & Farombi, E. O. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00834.x · Cited by 57
Werner, H., & Sarfstein, R. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.03.006 · Cited by 57
“The ubiquitin ligase Mdm2 is of primary importance in regulation of p53 activity [34].”
BackgroundTakeba, Y., Kumai, T., Matsumoto, N., Nakaya, S., Tsuzuki, Y., Yanagida, Y., & Kobayashi, S. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070442 · Cited by 62
Wilson, P. M., Fazzone, W., LaBonte, M. J., Lenz, H., & Ladner, R. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn910 · Cited by 64
“Mutations in the p53 tumor suppressor gene are reported in a wide variety of cancers and in >50% of colon cancers (35).”
BackgroundLackinger, D., Eichhorn, U., & Kaina, B. (2001) · Mutagenesis · doi:10.1093/mutage/16.3.233 · Cited by 60
“At the same time, the DNA binding ability of p53 is been found to harbour binding sites for both AP-1 and p53 in enhanced (Lakin and Jackson, 1999).”
BackgroundTomicic, M. T., Aasland, D., Naumann, S. C., Meise, R., Barckhausen, C., Kaina, B., & Christmann, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0953 · Cited by 56
Hideshima, T., Cottini, F., Nozawa, Y., Seo, H., Ohguchi, H., Samur, M., Cirstea, D. D., Mimura, N., Iwasawa, Y., Richardson, P. G. G., et al. (2017) · Blood · doi:10.1182/blood-2016-09-738500 · Cited by 60
Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
Ferraiuolo, M. A., Verduci, L., Blandino, G., & Strano, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050961 · Cited by 56
“It has been shown that different types of DNA damage, such as ionizing radiation, chemicals, radiomimetic drugs, ultraviolet radiation, and some pharmacological treatments can induce DNA damage [50].”
BackgroundHan, S., Shin, H., Lee, J., Liu, Z., Rabadán, R., Lee, J., Shin, J., Lee, C., Yang, H., Kim, D., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0351-y · Cited by 60
Splicing DNA-damage responses to tumour cell death
Crighton, D., & Ryan, K. M. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.001 · Cited by 63
Lee, J. G., Dahi, S., Mahimkar, R., Tulloch, N. L., Alfonso-Jaume, M., Lovett, D. H., & Sarkar, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508085102 · Cited by 56
Böhnke, A., Westphal, F., Schmidt, A., El-Awady, R. A., & Dahm‐Daphi, J. (2004) · International Journal of Radiation Biology · doi:10.1080/09553000310001642902 · Cited by 56
“DNA damage is one of the best known activators of p53 (Nelson and Kastan 1994, Lakin and Jackson 1999), which in turn is suggested to have significant impact on cellular sensitivity.”
Background
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.